CARA250117P5000
- 0.00
- 0.000.00%
Cara Therapeutics Newsroom
Top Premarket Decliners
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Cara Jumps on All-stock Merger Deal With Tvardi
Shareholder Alert: Ademi LLP Investigates Whether Cara Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Express News | Cara Therapeutics Inc - Imran Alibhai to Serve as CEO of Combined Company
Express News | Trading Halt: Halt Status Updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times
Cara Therapeutics Subsidiary to Merge With Tvardi Therapeutics in All-Stock Deal
Cara Therapeutics: Also Enters Into an Asset Purchase Agreement With Vifor Fresenius Medical Care Renal Pharma >CARA
Express News | Cara Therapeutics Inc - to Sell Korsuva/Kapruvia Assets to CSL Vifor
Express News | Cara Therapeutics Inc - Stockholders to Own 17% of Combined Company, Tvardi Investors 83%
Express News | Cara Therapeutics and Tvardi Therapeutics Announce Entry Into Merger Agreement
Express News | Trading Halt: Halted at 6:57:36 A.m. ET - Trading Halt: Halt News Pending
Cannabis Stock Gainers And Losers From November 29, 2024
Express News | Cara Therapeutics Inc - Receives Non-Compliance Notice From Nasdaq on Minimum Stockholders’ Equity Requirement
Cara Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Cara: Q3 Earnings Snapshot
Cara Therapeutics | 10-Q: Q3 2024 Earnings Report
Earnings Week Ahead: DIS, BABA, JD, CSCO, HD, OXY, SU, SHOP, AMAT, SPOT, and More
Express News | CSL Limited Reports 13.5% Stake in Cara Therapeutics Inc as of Oct 23 - SEC Filing
12 Health Care Stocks Moving In Friday's After-Market Session